US Stock MarketDetailed Quotes

RZLT Rezolute

Watchlist
  • 3.850
  • -0.020-0.52%
Close Mar 7 16:00 ET
  • 3.870
  • +0.020+0.52%
Post 20:01 ET
233.06MMarket Cap-3.13P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Tonyco
    Tonyco
    Feb 13 21:06
    I've had a busy few weeks, man. Everyone got the 'rona here, and it was a bad one.
    I'm cleaning my portfolio out a bit. Especially ones that don't seem to move on earnings.
    My time horizon is off on some of these, too. Dont want to wait for clinical trials right now. Too exposed to dilution with those cats.
    So far, I've cut
    $Dell Technologies (DELL.US)$ : Never will appease, especially now with more costs.
    $Intel (INTC.US)$ : They managed to get about 5B of their 8B owed from CHIPS, but with Tr...
    2
    Trytosaveabit
    Trytosaveabit
    Feb 4 07:02
    update
    $Rezolute (RZLT.US)$ Reuters· 1 min ago
    Rezolute Inc - DMC Reviewed Open-Label Arm for Infants, Target Drug Concentrations Safely Reached
    Jaguar8
    Jaguar8
    Feb 4 07:01
    NEWS
    $Rezolute (RZLT.US)$
    Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
    Tuesday, 4th February at 8:00 am
    Open-label arm (infant participants < 1 year old) has been recently reviewed by a Data Monitoring Committee (DMC) and target drug concentrations were safely reached at tested doses
    DMC approved enrollment of infants into the double-blind portion of the study
    sunRIZE enrollment completion expected in Q2 2025...
    Jaguar8
    Jaguar8
    Jan 7 07:11
    NEWS
    $Rezolute (RZLT.US)$
    Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
    Tuesday, 7th January at 8:00 am
    Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital hyperinsulinism (HI)
    Ersodetug continues to advance in clinical development as a potential treatment for hypoglycemia caused by all forms of hyperinsulinism; t...
Read more
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+8.64%
Qualcomm
QCOM
+3.32%
Oracle
ORCL
+2.80%
ASML Holding
ASML
+2.43%
NVIDIA
NVDA
+1.92%

Unlock the Full List